AQR Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

AQR Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.39M	Buy	8,255 +240	+3%	+$41K	﹤0.01%	2591
2025 Q4	$1.35M	Buy	8,015 +2,853	+55%	+$463K	﹤0.01%	2376
2025 Q3	$745K	Sell	5,162 -201	-4%	-$27.4K	﹤0.01%	2600
2025 Q2	$678K	Buy	5,363 +1,806	+51%	+$222K	﹤0.01%	2438
2025 Q1	$455K	Buy	+3,557	New	+$482K	﹤0.01%	2479
2023 Q3	–	Sell	-15,183	Closed	-$1.93M	–	2340
2023 Q2	$1.93M	Buy	+15,183	New	+$1.97M	﹤0.01%	1271

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AQR Capital Management's IBB Position: Q1 2026 in Review

AQR Capital Management increased its iShares Biotechnology ETF (IBB) stake by 3% in Q1 2026, buying an estimated $41K and bringing the position to 8,255 shares worth $1.39M. The position accounts for ﹤0.01% of the portfolio, ranked #2591.

AQR Capital Management first reported a position in IBB in Q2 2023 and has held it in 6 quarters since. The position peaked at $1.93M in Q2 2023. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

AQR Capital Management held 8,255 shares of iShares Biotechnology ETF worth $1.39M as of Q1 2026.
AQR Capital Management bought 240 iShares Biotechnology ETF shares in Q1 2026, an estimated $41K.
iShares Biotechnology ETF made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #2591 holding.
AQR Capital Management first reported a position in iShares Biotechnology ETF in Q2 2023 and has held it in 6 quarters since.
AQR Capital Management's iShares Biotechnology ETF position peaked at $1.93M in Q2 2023.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.